CONSTANT THERAPEUTICS TXA127 FOR COVID-19 TO ENTER NIH-FUNDED CLINICAL TRIAL AT 60 SITES AROUND THE U.S.

As the focus on the COVID-19 pandemic shifts to raising the number of vaccinated people around the world, U.S. researchers, funded by the NIH, are undertaking a large new clinical trial to find effective treatments, in the belief that while controllable, SARS-Cov-2 and its variants will continue to cause endemic disease in many parts of the world.

Read More